Search

Today, researchers from MSK Kids at Memorial Sloan Kettering Cancer Center (MSK) published results that examine elevated levels of a protein called prohibitin in the urine and tumors of children with Wilms’ tumors. Their findings could help doctors identify children who are at risk for disease recurrence and precisely tailor treatment to overcome drug resistance.

… Thursday, August 8, 2019 Today, researchers from MSK Kids at Memorial Sloan Kettering Cancer Center (MSK) published results that examine elevated levels of a protein called prohibitin in the urine and tumors of children with Wilms’ tumors. Their findings could help doctors identify children who are at

Meet the winners of the 2022 Robbins Family Awards for Excellence at Memorial Sloan Kettering Cancer Center.

… Wednesday, May 11, 2022 There was extra jubilation at this year’s Robbins Family Awards for Nursing Excellence , because they were held in person in the Rockefeller Research Laboratory auditorium for the first time since 2019. The May 11, 2022, event, named for longtime board member Clifton S. Robbins

Memorial Sloan Kettering has created a new multidisciplinary research center that promises to shed light on the role that microbes and the body's inflammatory and immunological responses to them play in the development of cancer.

… Tuesday, June 1, 2010 Summary Memorial Sloan Kettering has created a new multidisciplinary research center that promises to shed light on the role that microbes and the body’s inflammatory and immunological responses to them play in the development of cancer. Experts estimate that up to 30 percent of

Learn more about the risks and benefits of the shingles vaccine for cancer patients and their caregivers.

… Tuesday, January 13, 2026 If you have cancer, you are at high risk for shingles, a painful rash caused by the same virus as chickenpox. The shingles vaccine is safe and helps protect you. We strongly recommend the shingles vaccine for people in our care with cancer.​ Mini Kamboj, MD , MSK’s Chief Medical

Learn how a support group could help you if you’ve been diagnosed with metastatic breast cancer.

… Tuesday, October 17, 2017 Summary A support group can be beneficial for any person diagnosed with cancer but especially those with metastatic breast cancer . Social worker Roz Kleban explains why. Nothing about cancer is easy, and Roz Kleban understands that. Ms. Kleban has been a social worker in the

Informal fall and winter gatherings promoted and encouraged fellowship among students.

… Monday, March 1, 2010 Fostering a rich, supportive, and diverse community in which to study is high on the school’s agenda. Informal fall and winter gatherings promoted and encouraged fellowship among students. A School Tradition — Celebrate Halloween At Gerstner Sloan Kettering, Halloween is one of

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and honors, given by the American Association for Cancer Research (AACR), the American Society of Clinical Oncology (ASCO), and the American Society of Hematology (ASH) organizations.

… Monday, June 22, 2020 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and honors to our staff, given by the American Association for Cancer Research (AACR) , the American Society of Clinical Oncology (ASCO) , and the American Society of Hematology (ASH) organizations: American

Clinically meaningful secondary cancer occurred in non-small cell lung cancer survivors, both within and beyond the thorax and over a prolonged period, according to a new study by a multidisciplinary team of lung cancer experts at MSK. The findings underscore the importance of risk-adapted, symptom-responsive survivorship care that includes evaluating heritable risk.

… Thursday, January 22, 2026 Clinically meaningful secondary cancer occurred in non-small cell lung cancer (NSCLC) survivors, both within and beyond the thorax and over a prolonged period, according to a new study by a multidisciplinary team of lung cancer experts at Memorial Sloan Kettering Cancer Center

MSK researchers presented exciting advances in medical oncology for a range of cancer types at the ESMO Congress 2025. Highlights included the latest updates on three phase 1 trials testing innovative treatment approaches for select patients with advanced solid tumors, NSCLC, and pancreatic cancer. MSK researchers also presented new insights about mismatch repair deficient solid tumors that may inform tailoring personalized treatments.

… Monday, October 20, 2025 Memorial Sloan Kettering Cancer Center (MSK) researchers presented exciting advances in medical oncology for a range of cancer types at the European Society for Medical Oncology Congress 2025 held October 17 to 21 in Berlin, Germany. Highlights included the latest updates on

In a study of patient tumor samples, researchers have found common mutations in parts of the genome that control gene regulation.

… Thursday, November 13, 2014 Summary In a study of patient tumor samples, researchers have found common mutations in parts of the genome that control gene regulation. About three billion base pairs make up the human genome. But less than 2 percent of that material contains the sequences for genes that